<DOC>
	<DOC>NCT00366158</DOC>
	<brief_summary>The primary efficacy objective of this clinical investigation is to demonstrate that the Ventricular Intrinsic Preference (VIPâ„¢) feature allows to reduce the medium- and long-term incidence of unnecessary ventricular pacing in patients with intact AV conduction.</brief_summary>
	<brief_title>EVITA: Evaluation of VIP Feature in Pacemaker Patients</brief_title>
	<detailed_description />
	<criteria>Patient has an indication for implantation of a dualchamber pacemaker; Patient is implanted or scheduled to be implanted with a St Jude Medical Victory pacemaker, or newer device with the same study relevant feature. Patient has persistent or permanent AF/AFl; Patient has permanent AV Block; Patient has a pacemaker replacement; Patient is in NYHA class IV; Patient is unable to attend the followup visits; Patient is pregnant; Patient is less than 18 years of age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Patients with intact AV conduction</keyword>
</DOC>